Drug-1,3,4-Thiadiazole Conjugates as Novel Mixed-Type Inhibitors of Acetylcholinesterase: Synthesis, Molecular Docking, Pharmacokinetics, and ADMET Evaluation
作者:Rabail Ujan、Aamer Saeed、Pervaiz Channar、Fayaz Larik、Qamar Abbas、Mohamed Alajmi、Hesham El-Seedi、Mahboob Rind、Mubashir Hassan、Hussain Raza、Sung-Yum Seo
DOI:10.3390/molecules24050860
日期:——
reference drug (neostigmine methyl sulfate; IC50 2186.5 ± 98.0 nM). Kinetic studies were performed to elucidate the mode of inhibition of the enzyme, and the compounds showed mixed-type mechanisms for inhibiting AChE. The Ki of 3b (0.0031 µM) indicates that it can be very effective, even at low concentrations. Compounds 3a–3i all complied with Lipinski’s Rule of Five, and showed high drug-likeness scores
合成、表征和评估了一个小型的新药 1,3,4-噻嗪唑杂化化合物库 (3a-3i),并评估了它们的乙酰胆碱酯酶 (AChE) 抑制和自由基清除活性。新合成的衍生物对 AChE 显示出有前景的活性,尤其是化合物 3b (IC50 18.1 ± 0.9 nM),它是该系列中最有前途的分子,并且比参考药物(甲基硫酸新斯的明;IC50 2186.5 ± 98.0 nM )。进行了动力学研究以阐明酶的抑制模式,并且这些化合物显示出抑制 AChE 的混合型机制。3b 的 Ki (0.0031 µM) 表明它非常有效,即使在低浓度下也是如此。化合物 3a-3i 均符合 Lipinski 的五法则,并显示出较高的药物相似性评分。药代动力学参数显示出显着的铅样特性,对肝脏和皮肤的渗透作用不明显。构效关系 (SAR) 分析表明与 Tyr124、Trp286 和 Tyr341 相关的关键氨基酸残基存在 π-π 相互作用。